Vivos Therapeutics Overview

Vivos Therapeutics Other Income Expense Net

Other Income/Expense Net for VVOS.

Quarterly Other Income/Expense

-$1.59M

↓ 1192.68% YoY

As of Mar 31, 2026

Annual Other Income/Expense (TTM)

$17.13M

↑ 4381.25% YoY

Trailing 12 months ending Mar 31, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin